Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Hinyokika Kiyo. Acta Urologica Japonica|February 16, 2013
[A case of prostate cancer presenting as extensive abdominal metastasis]Yuko Shirono, Shugo Hanyu, Toshihiko IkarashiJournal of Rural Medicine : JRM|June 8, 2018
Conservative management of bilateral traumatic testicular dislocation in a 10-year-old boyYuko Shirono, Shunsuke Yamaguchi, Eisuke Takahashi, et al.Oncology Letters|December 7, 2020
Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatmentHiroo Kuroki, Tsutomu Anraku, Akira Kazama, et al.Current Issues in Molecular Biology|January 24, 2025
Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAPKaede Hiruma, Vladimir Bilim, Akira Kazama, et al.Journal of Personalized Medicine|October 27, 2022
Advanced Bladder Cancer: Changing the Treatment LandscapeVladimir Bilim, Hiroo Kuroki, Yuko Shirono, et al.Current Issues in Molecular Biology|September 27, 2023
MicroRNAs as Potential Regulators of GSK-3β in Renal Cell CarcinomaMasaki Murata, Vladimir Bilim, Yuko Shirono, et al.Journal of Personalized Medicine|July 27, 2024
Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell CarcinomaTsutomu Anraku, Masaki Murata, Hiroo Kuroki, et al.Current Oncology (Toronto, Ont.)|June 27, 2023
Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer CellsYuko Shirono, Vladimir Bilim, Tsutomu Anraku, et al.Oncology Reports|September 1, 2021
Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinomaAkira Kazama, Tsutomu Anraku, Hiroo Kuroki, et al.Scientific Reports|November 27, 2022
Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinomaAkira Kazama, Vladimir Bilim, Masayuki Tasaki, et al.Pageof 2